BFRI
BFRI
NASDAQ · Pharmaceuticals

Biofrontera Inc

$1.27
+0.02 (+1.60%)
As of Aug 8, 10:57 PM ET ·
Financial Highlights (FY 2026)
Revenue
53.33M
Net Income
-13,473,889
Gross Margin
73.7%
Profit Margin
-25.3%
Rev Growth
+13.3%
D/E Ratio
0.44
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 59.5% 59.5%
Operating Margin -27.2% -24.5% 39.9% 36.7%
Profit Margin -25.3% -24.0% 28.1% 33.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 53.33M 47.07M 1.67M 1.59M
Gross Profit 39.31M 34.69M 993.6K 946.5K
Operating Income -14,512,073 -11,526,666 666.0K 584.8K
Net Income -13,473,889 -10,702,056 470.0K 528.6K
Gross Margin 73.7% 73.7% 59.5% 59.5%
Operating Margin -27.2% -24.5% 39.9% 36.7%
Profit Margin -25.3% -24.0% 28.1% 33.2%
Rev Growth +13.3% +13.3% +24.3% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.48M 2.48M 868.4K 1.11M
Total Equity 5.65M 5.65M 5.54M 6.06M
D/E Ratio 0.44 0.44 0.16 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,336,332 -12,019,694 856.8K 789.7K
Free Cash Flow 585.2K 384.5K